Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-05 4:56 pm Purchase |
2022-05-03 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 6,841,423 12.600% |
894,100 (+15.03%) |
Filing History |
| 2022-02-14 08:59 am Purchase |
2021-12-31 | 13G | Passage Bio, Inc. PASG |
Deep Track Capital, LP | 3,216,997 5.950% |
364,057 (+12.76%) |
Filing History |
| 2022-02-14 07:01 am Unchanged |
2021-12-31 | 13G | Passage Bio, Inc. PASG |
Access Industries Holdings LLC | 2,616,630 4.800% |
0 (Unchanged) |
Filing History |
| 2022-02-09 12:22 pm Sale |
2021-12-31 | 13G | Passage Bio, Inc. PASG |
LAV Prescience Ltd | 2,199,676 4.100% |
-627,652 (-22.20%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Passage Bio, Inc. PASG |
BlackRock Inc. BLK |
3,491,555 6.500% |
3,491,555 (New Position) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | Passage Bio, Inc. PASG |
FMR LLC | 2,667,917 4.930% |
-2,610,183 (-49.45%) |
Filing History |
| 2021-10-25 5:12 pm Purchase |
2021-10-22 | 13G | Passage Bio, Inc. PASG |
Deep Track Capital, LP | 2,852,940 5.270% |
2,852,940 (New Position) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Passage Bio, Inc. PASG |
Vivo Capital VIII, LLC | 1,487,038 11.000% |
-756,459 (-33.72%) |
Filing History |
| 2021-02-11 5:05 pm Purchase |
2020-12-31 | 13G | Passage Bio, Inc. PASG |
New Leaf Ventures III L.P. | 2,497,922 4.700% |
2,497,922 (New Position) |
Filing History |
| 2021-02-09 4:23 pm Purchase |
2020-12-31 | 13G | Passage Bio, Inc. PASG |
LAV Prescience Ltd | 2,827,328 6.200% |
2,827,328 (New Position) |
Filing History |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | Passage Bio, Inc. PASG |
FMR LLC | 5,278,100 11.591% |
650,502 (+14.06%) |
Filing History |
| 2021-01-28 1:48 pm Unchanged |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 5,947,323 11.200% |
0 (Unchanged) |
Filing History |
| 2021-01-27 2:56 pm Purchase |
2021-01-26 | 13D | Passage Bio, Inc. PASG |
Frazier Life Sciences IX L.P. | 5,021,438 9.500% |
12,219 (+0.24%) |
Filing History |
| 2020-06-10 10:13 am Purchase |
2020-06-09 | 13G | Passage Bio, Inc. PASG |
FMR LLC | 4,627,598 10.204% |
4,627,598 (New Position) |
Filing History |